Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene

Nephrology Dialysis Transplantation

Volumn 13, Issue 5, 1998, Pages 1125-1130

  Tarnow, Lise ^a   Gluud, Christian ^b   Parving, Hans Henrik ^a  

^a STENO DIABETES CENTER   (Denmark)

^b The Capital Region   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL;

ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DNA TRANSPOSABLE ELEMENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE DELETION; GENOTYPE; HUMANS; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 0031960407     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.5.1125     Document Type: Article

References (42)

1. Eggers PW. Effect of transplantation on the Medicare end-stage renal disease program. N Engl J Med 1988; 318: 223-229
2. Seaquist ER, Goetz FC, Rich S et al. Familial clustering of diabetic kidney disease: evidence of genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161-1165
3. Borch-Johnsen K, Nørgaard K, Hommel E et al. Is diabetic nephropathy an inherited complication? Kidney Int 1992; 41: 719-722
4. Quinn M, Angelico MC, Warram JH et al. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996; 39: 940-945
5. Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. Br Med J 1987; 295: 515-517
6. Krolewski AS, Canessa H, Warram JH et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 140-145
7. Rigat B, Hubert C, Alhenc-Gelas F et al. An insertion/deletion polymorphism in angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346
8. Marre M, Bernadet P, Gallois Y et al. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43: 384-388
9. Tarnow L, Cambien F, Rossing P et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995; 44: 489-494
10. Cambien F, Poirier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644
11. Tarnow L, Cambien F, Rossing P et al. Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 1995; 38: 798-803
12. Ruiz J, Blanché H, Cohen N et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994; 91: 3662-3665
13. Schmidt S, Schöne N, Ritz E et al. Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 1995; 47: 1176-1181
14. Mizuiri S, Hemmi H, Inoue A et al. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995; 70: 455-459
15. Egger M, Smith GD, Schneider M et al. Bias in meta-analysis detected by a simple, graphical test. Br MedJ 1997; 315: 629-634
16. Yusuf S, Peto R, Lewis J et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335-371
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7: 177-188
18. The Cochrane Library (database on disk and CD-ROM). The Cochrane Collaboration. Oxford: Update Software; 1996. Updated quaterly
19. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 1994; 43: 690-695
20. Powrie JK, Watts GF, Ingham JN et al. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. Br Med J 1994; 309: 1608-1612
21. Chowdhury TA, Dronsfield MJ, Kumar S et al. Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia 1996; 39: 1108-1114
22. Ringel J, Beige J, Kunz R et al. Genetic variation of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia 1997; 40: 193-199
23. Barnas U, Schmidt A, Illievich A et al. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Diabetologia 1997; 40: 327-331
24. Marre M, Jeunemaitre X, Gallois Y et al Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 1997; 99: 1585-1595
25. Hibberd ML, Millward BA, Demaine AG. The angiotensin I-converting enzyme (ACE) locus is strongly associated with age and duration of diabetes in patients with type I diabetes. J Diabetes Complications 1997; 11: 2-8
26. Demurov LM, Chistyakov DA, Chugunova LA et al. Insertion/ deletion polymorphism of the angiotensin-converting enzyme gene in normalcy and among diabetics with vascular complications. Mol Biol 1997; 31: 49-52
27. Panagiotopoulos S, Smith TJ, Aldred GP et al. Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate. J Diabetes Complications 1995; 9: 272-276
28. Dudley CRK, Keavney BD, Stratton IM et al. U.K. Prospective Diabetes Study XV: relationship of renin angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995; 48: 1907-1911
29. Schmidt S, Ritz E. Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes. Nephrol Dial Transplant 1997; 12: 37-41
30. Jeffers BW, Estacio RO, Raynolds MV et al. Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int 1997; 52: 473-477
31. Fujisawa T, Ikegami H, Shen G-Q et al. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995; 18: 983-985
32. Doi Y, Yoshizumi H, Yoshinari M et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996; 39: 97-102
33. Ohno T, Kawazu S, Tomono S. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin dependent diabetics. Metabolism 1996; 45: 218-222
34. Nakajima S, Baba T, Yajuma Y. Is ACE gene polymorphism a useful marker for diabetic albuminuria in Japanese NIDDM patients? Diabetes Care 1996; 19: 1420-1422
35. Parving H-H, Østerby R, Anderson PW, Hsueh WA. Diabetic nephropathy. In: Brenner BM, ed. The Kidney. Saunders, Philadelphia: 1996: 1864-1892
36. Mogensen CE, Keane WF, Bennett PH et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995; 346: 1080-1084
37. Forsblom CM, Groop P-H, Ekslrand A et al. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. Br Med J 1992; 305: 1051-1053
38. Parving H-H, Jacobsen P, Tarnow L et al. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. Br Med J 1996; 313: 591-594
39. Schmidt S, Strojek K, Grzeszczak W et al. Excess of DD homozygotes in haemodialysed patients with type 11 diabetes. Nephrol Dial Transplant 1997; 12: 427-429
40. Yoshida H, Kuriyama S, Atsumi Y et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996; 50: 657-664
41. Staessen JA, Wang JG, Ginocchio G et al. The deletion/insertion polymorphism of the converting-enzyme gene and cardiovascular renal risk. J Hypertens 1998; 15: 1579-1592
42. Fujisawa T, Ikegami H, Kawaguchi Y et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 1998; 41: 47-53